Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hedera Dx has developed a CE-IVDR compliant liquid biopsy solution integrating NGS and proprietary software to enable rapid, in-house tumor profiling from blood samples. Their technology supports biomarker-guided treatment selection for cancer patients and has been validated through the EMPATHY NSCLC multicenter clinical study. The company’s approach streamlines molecular diagnostics workflows for hospital labs, aiming to expand access to precision oncology therapies globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hedera Dx.